| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.094 | 0.01 |
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.01 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.086 | 0.01 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.01 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.087 | 0.01 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.01 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.01 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | -0.086 | 0.01 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |